Inappropriate sinus tachycardia after hematopoietic stem cell transplantation

Journal of Pediatric Hematology/oncology
David BuchbinderTheodore Moore

Abstract

Survivors of childhood cancer and hematopoietic stem cell transplantation are subject to a range of cardiac late effects including conduction abnormalities. We present, the case of a 12-year-old girl diagnosed with inappropriate sinus tachycardia after a history of multiply relapsed acute lymphoblastic leukemia and an exposure history including anthracycline-based chemotherapy followed by the total body irradiation in the context of a hematopoietic stem cell transplant. The clinical importance of this late cardiac effect along with the potential options for therapy is discussed.

References

Jul 1, 1992·The American Journal of Cardiology·R L LarsenG Barber
Jul 1, 1991·Pacing and Clinical Electrophysiology : PACE·M S SlamaG Motté
May 1, 1993·International Journal of Cardiology·F OrzanL Libero
Jul 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L HancockR T Hoppe
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Jacob AdamsSteven E Lipshultz
Mar 15, 2005·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Aino-Maija StillHeikki V Huikuri
Apr 24, 2008·British Journal of Haematology·André TichelliGérard Socié
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianSmita Bhatia

❮ Previous
Next ❯

Citations

Oct 29, 2013·BMC Pediatrics·Robert J SchrothMichael E K Moffatt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.